Search

本信息将帮助您了解什么是淋巴水肿以及您发生淋巴水肿的风险。

… 本信息将帮助您了解什么是淋巴水肿以及您发生淋巴水肿的风险。 关于淋巴系统 图 1. 正常淋巴引流 图 1. 正常淋巴引流 淋巴系统承担两项工作： 帮助抵抗感染。 帮助排出身体部位的液体。 淋巴系统由淋巴结、淋巴管和淋巴液组成（见图 1）。 淋巴结 是沿淋巴管分布的豆状小腺体。 淋巴结可以过滤淋巴液，清除细菌、病毒、癌细胞和其他废物。 淋巴管 是像血管一样的微小管道，负责将液体输送至淋巴结或将淋巴结处的液体输送到其他部位。 淋巴液 是流经淋巴系统的一种透明液体。 它会携带有助于对抗感染和其他疾病的细胞。 Missing content item. Missing content item. 在乳腺癌手术过程中

Meet the team behind MSK News, which publishes each spring and fall.

… The MSK News Team EXECUTIVE VICE PRESIDENT, CHIEF MARKETING & COMMUNICATION OFFICER Erin McDonough, MBA SENIOR VICE PRESIDENT & CHIEF DEVELOPMENT OFFICER Ken Manotti CHIEF CONTENT OFFICER Ami Schmitz SENIOR DIRECTOR, EDITORIAL Katie Sobolik MANAGING EDITOR Bill Piersol CREATIVE DIRECTOR Randi Press ASSOCIATE

I’m a nurse practitioner who provides care for people with urological cancers. This includes prostate cancer, bladder cancer, and kidney cancer. I see patients at the Sidney Kimmel Center for Prostate and Urologic Cancers.

… Job Title Nurse Practitioner I’m a nurse practitioner with more than 5 years of experience in caring for people with urological cancers. This includes prostate cancer , bladder cancer , and kidney cancer . At Memorial Sloan Kettering Cancer Center (MSK), I provide support to patients and help them understand

… Job Title Senior Research Technician Email [email protected]

Learn about what DNA repair looks like under a microscope.

… Friday, May 19, 2017 Summary When DNA is damaged, a cell stops dividing and recruits “lifeguard proteins” and repair proteins to get its life cycle back on track. The first microscope was invented almost 500 years ago, when two Dutch scientists placed lenses in a tube and found that they could magnify

MSK investigators report exciting results for a new molecule that can block 16 different mutated forms of the KRAS protein. In the lab, the compound was effective against many cancer cell lines and in mouse models of lung cancer and colorectal cancer.

… Wednesday, May 31, 2023 KRAS was one of the first cancer genes ever discovered, but for a long time the cancer-causing KRAS protein was considered “undruggable” with targeted therapy. That started to change in May 2021, when the Food and Drug Administration granted accelerated approval to sotorasib (

Cycle for Survival, the official rare cancer fundraising event of Memorial Sloan Kettering Cancer Center (MSK), will begin its 2024 signature team stationary-cycling events. As the founding partner of Cycle for Survival, Equinox will have its instructors leading high-energy rides across the country. 100% of the funds raised go directly to rare cancer research at MSK.

… Friday, February 2, 2024 Cycle for Survival, the official rare cancer fundraiser for Memorial Sloan Kettering Cancer Center (MSK), will kick off its annual team stationary-cycling fundraising events this weekend. Its community of people with rare cancers, survivors, caregivers, supporters, doctors, researchers

Our laboratory employs an interdisciplinary approach combining cell biology and biochemistry, as well as mouse and computational models to dissect the contributions of chromosomal instability toward three key processes in human cancer: therapeutic resistance, immune evasion, and metastasis.

… Our laboratory employs an interdisciplinary approach combining cell biology, biochemistry, as well as mouse and computational models to dissect the contributions of chromosomal instability (CIN) toward three key processes in human cancer: therapeutic resistance, immune evasion, and metastasis. Major

An analysis of germline DNA in people with advanced cancer finds that inherited mutations may be more common than expected in this group.

… Tuesday, September 5, 2017 Summary An analysis of germline DNA in people with advanced cancer finds that inherited mutations may be more common than expected in this group. The findings have implications for genetic counseling and screening. Memorial Sloan Kettering’s genomic-sequencing test, called

September is Pediatric Cancer Awareness Month and at MSK, we continue to work to advance research to bring about better treatments and awareness to our youngest and most vulnerable patients not only in September, but every day.

… Tuesday, September 1, 2020 When we think about progress in fighting cancer, some of the most hopeful stories over the last few years have involved advances in treating children diagnosed with pediatric cancers. Once uniformly fatal, today, many children are thriving, beating the odds that once were stacked